Intercept Pharma Logo Image

Intercept Pharma

Intercept Pharma Banner Image

Most Recent Annual Report

2019 Annual Report and Form 10K

Intercept Pharma

Intercept Pharma has reached its limit for free report views.

Intercept Pharma does not currently have any hardcopy reports on Click the button below to request a report when hardcopies become available.

Archived Annual Reports

About Intercept Pharma

201-500 Employees
Based in New York City, New York

Intercept is a biopharmaceutical company focused on the development and commercialization of novel therapeutics to treat non-viral, progressive liver diseases, including primary biliary cholangitis (PBC), nonalcoholic steatohepatitis (NASH), primary sclerosing cholangitis (PSC) and biliary atresia.

NASDAQ (See More NASDAQ Companies)
Biotechnology (See More Biotechnology Companies)
Healthcare (See More Healthcare Companies)

Looking for Other Annual Reports?

Search by company name or ticker symbol